Back to Search

STEVEN ALBELDA, MD

MD

Pulmonary Disease Physician

NPI: 1730111733Individual

Specialties, Licenses & Credentials

Pulmonary Disease PhysicianPrimary

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

MD024774E(PA)

Research & Publications (20)

Role for platelet-endothelial cell adhesion molecule-1 in macrophage Fcgamma receptor function.
PMID 15087304·Am J Respir Cell Mol Biol·2004
7-preclinical
Pulmonary genetics, genomics, and gene therapy: conference summary.
PMID 11893726·Chest·2002
7-preclinical
Gene therapy for lung neoplasms.
PMID 11901916·Clin Chest Med·2002
6-review
Functional genomics and expression profiling: be there or be square.
PMID 10970813·Am J Respir Cell Mol Biol·2000
6-review
Gene therapy for lung disease: hype or hope?
PMID 10766684·Ann Intern Med·2000
6-review
Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.
PMID 19342415·Am J Respir Crit Care Med·2009
4-observational
Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.
PMID 19201924·Am J Respir Crit Care Med·2009
3-trial
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer.
PMID 19671764·Mol Cancer Ther·2009
8-other
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.
PMID 19211796·Proc Natl Acad Sci U S A·2009
7-preclinical
Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma.
PMID 18828194·Crit Care Med·2008
8-other
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers.
PMID 18559619·Clin Cancer Res·2008
7-preclinical
Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.
PMID 18606202·J Control Release·2008
8-other
RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.
PMID 18182571·Blood·2008
7-preclinical
B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
PMID 18463540·J Immunother·2008
7-preclinical
Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature.
PMID 18045968·Blood·2008
7-preclinical
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
PMID 19074893·Cancer Res·2008
7-preclinical
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.
PMID 17950837·Biomaterials·2008
7-preclinical
Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells.
PMID 18818761·PLoS One·2008
7-preclinical
Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide.
PMID 17712041·J Pharmacol Exp Ther·2007
8-other
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
PMID 17671130·Clin Cancer Res·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3400 SPRUCE STREET, 3 RAVDIN BLDG. STE. F
PHILADELPHIA, PA 19104

Location

Practice Location

3400 SPRUCE STREET, PHILADELPHIA, PA
(215) 662-3202

Quick Facts

NPI
1730111733
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile